ATE245650T1 - Pyrazolopyimidinon-derivate zur behandlung von impotenz - Google Patents
Pyrazolopyimidinon-derivate zur behandlung von impotenzInfo
- Publication number
- ATE245650T1 ATE245650T1 AT99954478T AT99954478T ATE245650T1 AT E245650 T1 ATE245650 T1 AT E245650T1 AT 99954478 T AT99954478 T AT 99954478T AT 99954478 T AT99954478 T AT 99954478T AT E245650 T1 ATE245650 T1 AT E245650T1
- Authority
- AT
- Austria
- Prior art keywords
- derivatives
- treatment
- pyrazolopyimidinone
- impotency
- impotence
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Gynecology & Obstetrics (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR19980048100 | 1998-11-11 | ||
KR19990014972 | 1999-04-27 | ||
KR19990049384A KR100353014B1 (ko) | 1998-11-11 | 1999-11-09 | 발기부전 치료에 효과를 갖는 피라졸로피리미디논 화합물 |
PCT/KR1999/000675 WO2000027848A1 (en) | 1998-11-11 | 1999-11-10 | Pyrazolopyrimidinone derivatives for the treatment of impotence |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE245650T1 true ATE245650T1 (de) | 2003-08-15 |
Family
ID=27349839
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT99954478T ATE245650T1 (de) | 1998-11-11 | 1999-11-10 | Pyrazolopyimidinon-derivate zur behandlung von impotenz |
Country Status (17)
Country | Link |
---|---|
US (1) | US6583147B1 (da) |
EP (1) | EP1129093B1 (da) |
JP (1) | JP3577630B2 (da) |
KR (1) | KR100353014B1 (da) |
CN (1) | CN1136219C (da) |
AT (1) | ATE245650T1 (da) |
AU (1) | AU760422B2 (da) |
BR (1) | BRPI9915822B8 (da) |
CA (1) | CA2350538C (da) |
DE (1) | DE69909818T2 (da) |
DK (1) | DK1129093T3 (da) |
ES (1) | ES2204169T3 (da) |
HK (1) | HK1039328B (da) |
NZ (1) | NZ511015A (da) |
PT (1) | PT1129093E (da) |
TR (1) | TR200101335T2 (da) |
WO (1) | WO2000027848A1 (da) |
Families Citing this family (42)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU6154700A (en) * | 1999-06-23 | 2001-01-31 | Centre National De La Recherche Scientifique (C.N.R.S.) | Therapeutic methods and compositions for the treatment of impaired interpersonal and behavioral disorders |
YU59100A (sh) * | 1999-10-11 | 2003-10-31 | Pfizer Inc. | Postupak za dobijanje pirazolo (4,3-d) pirimidin-7-ona-3-piridilsulfonil jedinjenja i njihova intermedijera |
KR100377782B1 (ko) * | 2000-06-23 | 2003-03-29 | 동아제약 주식회사 | 발기부전 치료에 효과를 갖는 피라졸로피리미디논화합물의 제조방법 |
WO2003053975A1 (fr) * | 2001-12-13 | 2003-07-03 | Daiichi Suntory Pharma Co., Ltd. | Derives de pyrazolopyrimidinone possedant une activite inhibitrice de pde7 |
RU2331438C2 (ru) | 2002-12-13 | 2008-08-20 | Уорнер-Ламберт Компани Ллс | Альфа-2-дельта лиганд для лечения симптомов нижних мочевыводящих путей |
WO2004082667A1 (en) * | 2003-03-17 | 2004-09-30 | Pfizer Products Inc. | Treatment of type 1 diabetes with pde5 inhibitors |
CN100374441C (zh) | 2003-06-06 | 2008-03-12 | 天津倍方科技发展有限公司 | 二氢吡咯[2,3-d]嘧啶-4-酮衍生物,其制备方法及其制药用途 |
BRPI0506994A (pt) | 2004-01-22 | 2007-07-03 | Pfizer | derivados de triazol que inibem a atividade antagonista da vasopressina |
US7649002B2 (en) | 2004-02-04 | 2010-01-19 | Pfizer Inc | (3,5-dimethylpiperidin-1yl)(4-phenylpyrrolidin-3-yl)methanone derivatives as MCR4 agonists |
EA200701752A1 (ru) * | 2005-02-18 | 2008-04-28 | Сурфейс Логикс Инк. | Способ получения усовершенствованных фармакокинетических соединений, включающих функциональные остатки или группы, и фармацевтические композиции, содержащие эти соединения |
CA2598271A1 (en) * | 2005-02-18 | 2006-08-24 | Surface Logix, Inc. | Pharmacokinetically improved compounds |
PT2366393E (pt) | 2005-04-19 | 2013-10-04 | Takeda Gmbh | Roflumilaste para o tratamento da hipertensão pulmonar |
EP1888074B1 (en) * | 2005-06-10 | 2011-12-21 | Dong-A Pharmaceutical Co., Ltd. | Agent for the prevention and treatment of liver diseases containing pyrazolopyrimidine derivative |
CN1966506A (zh) * | 2005-11-17 | 2007-05-23 | 上海特化医药科技有限公司 | 吡唑并嘧啶酮衍生物及其制备方法和用途 |
EE05532B1 (et) * | 2006-04-04 | 2012-04-16 | Dong-A Pharmaceutical Co., Ltd. | Pürasolopürimidinoonühendit sisaldav farmatseutiline kompositsioon eesnäärme- suurenemuse ärahoidmiseks ja raviks |
WO2007141805A2 (en) * | 2006-06-05 | 2007-12-13 | Matrix Laboratories Limited | Novel process for the preparation of sildenafil citrate |
AR062501A1 (es) | 2006-08-29 | 2008-11-12 | Actelion Pharmaceuticals Ltd | Composiciones terapeuticas |
EP2063890A1 (en) | 2006-09-07 | 2009-06-03 | Nycomed GmbH | Combination treatment for diabetes mellitus |
US20090270425A1 (en) * | 2006-10-20 | 2009-10-29 | Concert Pharmaceuticals Inc. | 3-(dihydro-1h-pyrazolo[4,3-d]pyrimidin-5-yl)-4-propoxybenzenesulfonamide derivatives and methods of use |
MX2009003941A (es) * | 2006-10-20 | 2009-04-24 | Concert Pharmaceuticals Inc | Derivados de 3-(dihidro-1h-pirazolo[4,3-d]pirimidin-5-il)-4-propox ibencenosulfonamida y metodos de uso. |
US20090197899A1 (en) * | 2006-10-20 | 2009-08-06 | Concert Pharmaceuticals Inc. | 3-(Dihydro-1H-pyrazolo[4,3-d]pyrimidin-5-yl)-4-propoxybenzenesulfonamide Derivatives and Methods of Use |
US20080194529A1 (en) * | 2007-02-12 | 2008-08-14 | Auspex Pharmaceuticals, Inc. | HIGHLY SELECTIVE and LONG-ACTING PDE5 MODULATORS |
RU2450017C2 (ru) | 2007-05-25 | 2012-05-10 | Ипсен Фарма С.А.С. | Лиганды меланокортиновых рецепторов, модифицированные гидантоином |
MX2009013354A (es) | 2007-06-04 | 2010-07-06 | Univ Ben Gurion | Compuestos de triarilo y composiciones que los contienen. |
KR101002490B1 (ko) * | 2007-06-09 | 2010-12-17 | 동아제약주식회사 | 유데나필을 유효성분으로 함유하는 만성 심부전증 치료용약학적 조성물 |
US20100210668A1 (en) * | 2007-10-02 | 2010-08-19 | Dong-A Pharm. Co., Ltd. | Composition and method for treatment or prevention of benign prostatic hyperplasia and lower urinary tract symptoms |
KR100920125B1 (ko) * | 2007-10-02 | 2009-10-01 | 동아제약주식회사 | 양성 전립선 비대증 치료를 위한 피라졸로피리미디논화합물 및 알파 아드레날린성 수용체 길항제를 함유하는약제학적 배합물 |
WO2009099620A1 (en) * | 2008-02-04 | 2009-08-13 | Concert Pharmaceuticals Inc. | 3-(dihydro-1h-pyrazolo[4,3-d]pyrimidin-5-yl)-4-propoxybenzenesulfonamide derivatives and methods of use |
KR20090087795A (ko) * | 2008-02-13 | 2009-08-18 | 한양대학교 산학협력단 | 혈관 재협착 예방 및 치료를 위한 약학 조성물 및 이를포함하는 스텐트 |
KR101071877B1 (ko) * | 2009-02-18 | 2011-10-10 | 동아제약주식회사 | 유데나필 산부가염, 그의 제조방법 및 이를 포함하는 약학적 조성물 |
GB0903493D0 (en) | 2009-02-27 | 2009-04-08 | Vantia Ltd | New compounds |
EP2556820A4 (en) | 2010-04-05 | 2015-01-21 | Sk Chemicals Co Ltd | COMPOSITION CONTAINING PDE5 INHIBITOR FOR MITIGATION OF SKIN WRINKLES |
CN102952138B (zh) * | 2011-08-17 | 2016-07-06 | 上海特化医药科技有限公司 | 一种吡唑并嘧啶酮化合物的盐、多晶型物及其药物组合物、制备方法和应用 |
EP2821066B1 (en) | 2012-02-28 | 2018-04-25 | Seoul Pharma. Co. Ltd. | High-content fast dissolving film with masking of bitter taste comprising sildenafil as active ingredient |
KR101953735B1 (ko) | 2012-12-14 | 2019-03-04 | 한미약품 주식회사 | 포스포다이에스터라제-5 억제제를 포함하는 츄정 |
US10111880B2 (en) | 2013-11-05 | 2018-10-30 | Ben-Gurion University Of The Negev Research And Development Authority | Compounds for the treatment of diabetes and disease complications arising from same |
WO2016025100A2 (en) * | 2014-08-12 | 2016-02-18 | Mezzion Pharma Co., Ltd. | Methods of improving myocardial performance in fontan patients using udenafil compositions |
KR101645652B1 (ko) | 2014-11-03 | 2016-08-08 | (주)퓨젠바이오농업회사법인 | 세리포리아 락세라타에 의해 생산되는 세포외다당체를 유효성분으로 함유하는 성기능개선용 조성물 |
WO2017168174A1 (en) | 2016-04-02 | 2017-10-05 | N4 Pharma Uk Limited | New pharmaceutical forms of sildenafil |
CN107759603B (zh) * | 2016-08-18 | 2020-09-01 | 四川科伦药物研究院有限公司 | 一种杂环化合物的制备方法 |
CN113493459B (zh) * | 2020-04-07 | 2022-12-13 | 广州白云山医药集团股份有限公司白云山制药总厂 | Pde5抑制剂化合物及其制备方法和应用 |
CA3201054A1 (en) | 2020-12-11 | 2022-06-16 | Yoon-Suk Lee | Novel compounds as androgen receptor and phosphodiesterase dual inhibitor |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9013750D0 (en) * | 1990-06-20 | 1990-08-08 | Pfizer Ltd | Therapeutic agents |
GB9114760D0 (en) * | 1991-07-09 | 1991-08-28 | Pfizer Ltd | Therapeutic agents |
GB9119704D0 (en) * | 1991-09-14 | 1991-10-30 | Pfizer Ltd | Therapeutic agents |
GB9301192D0 (en) * | 1993-06-09 | 1993-06-09 | Trott Francis W | Flower shaped mechanised table |
GB9423911D0 (en) * | 1994-11-26 | 1995-01-11 | Pfizer Ltd | Therapeutic agents |
GB9612514D0 (en) * | 1996-06-14 | 1996-08-14 | Pfizer Ltd | Novel process |
TR199902646T2 (xx) * | 1997-04-25 | 2000-05-22 | Pfizer Inc. | Seks�el bozuklu�un tedavisi i�in pirazolopirimidinonlar. |
KR100297814B1 (ko) * | 1998-12-29 | 2001-10-26 | 조민호 | 피라졸로피리미디논유도체와이의제조방법그리고이의용도 |
-
1999
- 1999-11-09 KR KR19990049384A patent/KR100353014B1/ko active IP Right Grant
- 1999-11-10 PT PT99954478T patent/PT1129093E/pt unknown
- 1999-11-10 ES ES99954478T patent/ES2204169T3/es not_active Expired - Lifetime
- 1999-11-10 AU AU10817/00A patent/AU760422B2/en not_active Expired
- 1999-11-10 CN CNB998127752A patent/CN1136219C/zh not_active Expired - Lifetime
- 1999-11-10 DK DK99954478T patent/DK1129093T3/da active
- 1999-11-10 BR BRPI9915822A patent/BRPI9915822B8/pt not_active IP Right Cessation
- 1999-11-10 TR TR2001/01335T patent/TR200101335T2/xx unknown
- 1999-11-10 WO PCT/KR1999/000675 patent/WO2000027848A1/en active IP Right Grant
- 1999-11-10 EP EP99954478A patent/EP1129093B1/en not_active Expired - Lifetime
- 1999-11-10 CA CA002350538A patent/CA2350538C/en not_active Expired - Lifetime
- 1999-11-10 NZ NZ511015A patent/NZ511015A/en not_active IP Right Cessation
- 1999-11-10 AT AT99954478T patent/ATE245650T1/de active
- 1999-11-10 JP JP2000581026A patent/JP3577630B2/ja not_active Expired - Lifetime
- 1999-11-10 US US09/831,433 patent/US6583147B1/en not_active Expired - Lifetime
- 1999-11-10 DE DE69909818T patent/DE69909818T2/de not_active Expired - Lifetime
-
2002
- 2002-01-25 HK HK02100595.7A patent/HK1039328B/zh not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
CA2350538A1 (en) | 2000-05-18 |
DE69909818D1 (de) | 2003-08-28 |
JP3577630B2 (ja) | 2004-10-13 |
BRPI9915822B8 (pt) | 2021-05-25 |
HK1039328A1 (en) | 2002-04-19 |
KR100353014B1 (ko) | 2002-09-18 |
EP1129093A1 (en) | 2001-09-05 |
US6583147B1 (en) | 2003-06-24 |
AU760422B2 (en) | 2003-05-15 |
PT1129093E (pt) | 2003-12-31 |
DE69909818T2 (de) | 2004-05-27 |
CN1325398A (zh) | 2001-12-05 |
ES2204169T3 (es) | 2004-04-16 |
AU1081700A (en) | 2000-05-29 |
CA2350538C (en) | 2005-06-28 |
HK1039328B (zh) | 2004-06-25 |
NZ511015A (en) | 2003-09-26 |
EP1129093B1 (en) | 2003-07-23 |
KR20000035324A (ko) | 2000-06-26 |
TR200101335T2 (tr) | 2001-09-21 |
WO2000027848A1 (en) | 2000-05-18 |
DK1129093T3 (da) | 2003-10-20 |
CN1136219C (zh) | 2004-01-28 |
BR9915822B1 (pt) | 2013-08-27 |
BR9915822A (pt) | 2001-08-14 |
JP2002529467A (ja) | 2002-09-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE245650T1 (de) | Pyrazolopyimidinon-derivate zur behandlung von impotenz | |
ATE223745T1 (de) | Zusammensetzung zur verbesserten elektroübertragunslieferung von wirkstoff | |
ATE337780T1 (de) | Indoly-lsulphonyl-verbindungen zur behandlung von störungen des zns | |
DE60029799D1 (de) | Verbindungen, verfahren und pharmazeutische zubereitungen zur behandlung von zellschäden wie zum beispiel schäden an nerven- oder kerzgefässgewebe | |
BR9911060A (pt) | Composições compreendendo mono- ou dinitrato orgânico para tratar impotência | |
ATE337316T1 (de) | Imidazo 1,2-aöpyridin-derivate zur prophylaxe und behandlung von herpes-infektionen | |
DE69830751D1 (de) | Polyaromatische Verbindungen zur Behandlung von Herpes-Infektionen | |
DE60112766D1 (de) | Verwendung von derivaten der valproinsäureamide und 2-valproinsäureamid zur behandlung und prävention von schmerzen und/oder kopfschmerzen | |
MY128241A (en) | Substituted tetracyclic pyrroloquinolone derivatives useful as phosphodiesterase inhibitors | |
DE69739970D1 (de) | Methode zur behandlung sexueller fehlfunktionen | |
AP2001002191A0 (en) | 3,3- Biarylpiperine and 2,2-biarylmorpholine derivatives. | |
DE60115466D1 (de) | Wirkstoffvorläufer von imidazopyridin-derivaten | |
DK1109814T3 (da) | 5-Heterocyclylpyrazolo[4,3-d]pyrimidin-7-oner til behandling af mandlig erektil dysfunktion | |
ATE225171T1 (de) | Aminosäurederivate zur behandlung von schlaganfall | |
PT1107793E (pt) | Conjugados de dextrano-leptina, composicoes farmaceuticas e processos relacionados | |
ATE267816T1 (de) | Tan-1057 derivate | |
ATE517626T1 (de) | Aminosubstituierte sulphonanilide und ihre derivate zur behandlung von proliferativen erkrankungen | |
ATE213233T1 (de) | Substituierte caprolactame und deren derivate verwendbar zur behandlung der hiv-krankheit | |
DK0773782T3 (da) | Terpenderivater (sarcodictyiner) anvendelse som antitumormidler | |
DE60131968D1 (de) | PYRANOÄ2,3-cÜIMIDAZOÄ1,2-aÜPYRIDIN-DERIVATE ZUR BEHANDLUNG VON GASTROINTESTINALEN ERKRANKUNGEN | |
ATE393624T1 (de) | Verwendung von sesquiterpene enthaltenden zusammenstellungen zur behandlung von krebs | |
ATE548048T1 (de) | Oncomodulin zur behandlung von neurologishen erkrankungen | |
ATE283269T1 (de) | 5-(heteroaryl)alkyl)-3-oxo-pyrido(1,2- a)benzimidazol-4-carboxamid (pbi) derivate zur behandlung von störungen des zentralen nervensystems | |
BG105549A (en) | Use of n-substituted azabicycloalkane derivatives for treating diseases of the central nervous system | |
DE50211752D1 (de) | Wässrige lösungen von moxaverin zur behandlung der erektilen dysfunktion |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification |
Ref document number: 1129093 Country of ref document: EP |
|
EEIH | Change in the person of patent owner | ||
EEIH | Change in the person of patent owner |